ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
A partnership between the European Commission and the European Federation of Pharmaceutical Industries & Associations, a drug industry group, has awarded $337 million for 15 research projects to develop generic and precompetitive knowledge. The call for project proposals attracted about 150 applicants. In this round, the partnership, known as the Innovative Medicines Initiative, will fund consortia—including small and medium-sized enterprises, academic institutions, and regulatory bodies—that will conduct research into areas such as pain management, neurodegenerative disorders, and severe asthma. A second call for proposals will be launched in the fall to fund projects in areas such as oncology, chronic inflammatory diseases, and infectious diseases.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter